MARCHI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 382
EU - Europa 378
AS - Asia 99
Totale 859
Nazione #
US - Stati Uniti d'America 382
PL - Polonia 108
IT - Italia 80
IE - Irlanda 58
SE - Svezia 50
RU - Federazione Russa 49
HK - Hong Kong 36
CN - Cina 27
SG - Singapore 19
JO - Giordania 10
GB - Regno Unito 9
DK - Danimarca 7
DE - Germania 4
VN - Vietnam 4
ES - Italia 3
FI - Finlandia 3
UA - Ucraina 3
CH - Svizzera 2
BY - Bielorussia 1
IN - India 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
Totale 859
Città #
Warsaw 108
Chandler 58
Dublin 58
Fairfield 52
Ashburn 36
Hong Kong 24
Moscow 23
Florence 19
Lawrence 18
Altamura 17
Woodbridge 17
Seattle 15
Wilmington 15
New York 14
Cambridge 13
Houston 13
Shanghai 12
Los Angeles 11
Princeton 11
Singapore 10
Ann Arbor 9
Buffalo 9
Medford 8
Alghero 7
Beijing 7
Boston 7
Copenhagen 7
Prato 7
Boardman 5
Kent 5
Naples 5
Dong Ket 4
Bilbao 3
San Diego 3
Bagno a Ripoli 2
Bern 2
Bologna 2
Falls Church 2
Kilburn 2
Lappeenranta 2
Lecce 2
Lodi 2
London 2
Wuhan 2
Amsterdam 1
Andover 1
Anguillara Sabazia 1
Arezzo 1
Chennai 1
Clifton 1
Guangzhou 1
Helsinki 1
Hillsboro 1
Norwalk 1
Phoenix 1
Rome 1
Rui'an 1
San Miniato Basso 1
Sapporo 1
Seoul 1
Southwark 1
Staranzano 1
Tavarnuzze 1
Viterbo 1
Wandsworth 1
Washington 1
Totale 672
Nome #
Muscle shortening maneuver and not topical anti-inflammatory therapy is effective in reducing the width of subacromial-subdeltoid bursa in shoulder impingement syndrome 175
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 111
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 77
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 69
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 57
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 55
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 53
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 51
Antiarrhythmic efficacy of anakinra in a young patient with autoimmune lymphocytic myocarditis 50
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 43
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care 27
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 24
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 18
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 18
Stage-specific therapy for hypertrophic cardiomyopathy 18
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 16
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 14
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 4
Totale 880
Categoria #
all - tutte 4.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020107 0 10 2 4 8 13 14 16 13 9 13 5
2020/2021146 8 12 0 31 16 9 7 7 24 10 13 9
2021/202291 5 0 1 4 2 14 0 3 9 8 16 29
2022/2023270 19 64 19 10 17 42 39 14 29 7 3 7
2023/2024188 8 11 20 10 21 24 15 35 4 19 14 7
2024/202562 34 28 0 0 0 0 0 0 0 0 0 0
Totale 880